Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study of Busulfan for Refractory Central Nervous System (CNS) Tumors

This study has been withdrawn prior to enrollment.
(slow accrual)
Sponsor:
Information provided by (Responsible Party):
Stewart Goldman, Ann & Robert H Lurie Children's Hospital of Chicago
ClinicalTrials.gov Identifier:
NCT00836628
First received: February 3, 2009
Last updated: February 4, 2016
Last verified: February 2016
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Study Completion Date: October 2010
  Primary Completion Date: October 2010 (Final data collection date for primary outcome measure)